Case Review Form

      * Denotes required field.


      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address




      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Dental Extraction During Bisphosphonate Therapy May Lead to ONJ

Filed September 14th, 2012 Laurie

In patients suffering from bisphosphonate-associated osteonecrosis of the jaw (ONJ), dental extraction was most often to blame for the condition. Italian researchers studied patients who were already suffering from multiple myeloma or Waldenstrom’s macroglobulinemia.

About 80 percent of the patients who had ONJ reported having recent dental alveolar surgery, including tooth extraction. All but one of the 55 cases involved some sort of dental procedure.

“A dental examination with preventive dentistry must be performed before starting [bisphosphonate] therapy, and some cautions must be used if dental problems appear during therapy,” the authors advised. “The use of antibiotics for germ eradication, the indication to avoid tooth removal and dental implants, and the implementation of nonsurgical control of periodontal disease are universally recognized.

The authors also added that bisphosphonate therapy should be individualized by patient, and should not continue for longer than 1 to 2 years.
Bisphosphonates are drugs that are typically used to treat bone conditions, like osteoporosis.

According to the report, diagnostic criteria for ONJ consisted of presence of exposed or necrotic bone of the maxilla or mandible with or without pain; evidence of regional soft-tissue inflammatory swelling or infection; exposed bone with pathologic fracture with pain, swelling, or cutaneous fistula.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!